Archive
Proactive news snapshot: ReNeuron Group PLC, Tissue Regenix Group PLC, ANGLE PLC, Motif Bio PLC …
A glance at some of the day's highlights from the Proactive Investors newswire
Company
LON:RENE
ReNeuron Group PLC has developed a proprietary stem cell-derived, exosome-based, drug delivery platform with customisable cellular targeting capabilities for the delivery of complex drug modalities. Through the generation of several unique and scalable exosome producer cell lines, its CustomEX ™ platform can be optimised for specific tissues targets and payloads leading to improvements in therapeutic outcome and a reduction in off-target effects. ReNeuron offers a delivery mechanism for a variety of payloads such as siRNA, mRNA, proteins, small molecules and genes.
298 stories · page 6 of 15
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
Mid-cap cousin FTSE 250 was also lower, shedding around 56 points at 19,507
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
The company's retinitis pigmentosa clinical programme benefits from orphan drug designation in both Europe and the US, as well as a fast track designation from the FDA in the US
Archive
A look back at some of the more interesting stories from the junior market over the past week
Some of the major news-driven risers and fallers on Wednesday …
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
The first three patients in a group taking part in the Phase II portion of the study were able on average able to read an additional three lines of on the standard ETDRS eye chart after receiving treatment
BIg banking group Lloyds was among the top gainers on Footsie
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
A look at the day's major movers, including Cambridge Cognition, SRT Marine, Redhall, FireAngel, Challenger Acquisitions, Alexander Mining and Blue Star Capital
Dr Nicola Goddard, of University College London, and her team have made a significant advance in the manufacture of exosomes, which are nanoparticles released by cells
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
A look at the day's major movers, including Tri-Star Resources, Quixant, Metals Exploration, NCC Group, Primary Health Properties, MedicX Fund, Nautical Marine Services, Blue Star Capital and Gama Aviation.
ReNeuron has developed CTX – a stem cell therapy that it believes can help improve the quality of life for people left disabled by a stroke
On the agenda at this year's Biotech Showcase is a panel discussion entitled “Cell and gene therapy: The financing surge” featuring Orgenesis CEO Vered Caplan
Investments and investor services
A look at the day's major movers, including ReNeuron, 7digital, Glenveagh, Gear4Music, Reach and McColl's
Archive
A glance at some of the day's highlights from the Proactive Investors newswire